HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sunil Krishnan Selected Research

CAN 508

4/2017Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sunil Krishnan Research Topics

Disease

155Neoplasms (Cancer)
11/2022 - 01/2003
29Rectal Neoplasms (Rectal Cancer)
07/2021 - 06/2006
26Pancreatic Neoplasms (Pancreatic Cancer)
12/2020 - 04/2007
25Adenocarcinoma
01/2022 - 12/2006
21Hepatocellular Carcinoma (Hepatoma)
01/2022 - 04/2008
18Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 12/2006
13Neoplasm Metastasis (Metastasis)
11/2019 - 12/2006
8Hyperthermia
10/2020 - 05/2008
8Stomach Neoplasms (Stomach Cancer)
05/2020 - 01/2008
7Breast Neoplasms (Breast Cancer)
11/2021 - 10/2010
7Carcinoma (Carcinomatosis)
07/2014 - 10/2006
6Prostatic Neoplasms (Prostate Cancer)
11/2022 - 05/2008
6Anus Neoplasms (Anal Cancer)
01/2018 - 11/2009
5Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2003
5Carcinogenesis
05/2021 - 05/2003
5Inflammation (Inflammations)
01/2020 - 05/2010
5Pathologic Complete Response
01/2018 - 12/2006
4Brain Neoplasms (Brain Tumor)
12/2021 - 01/2003
4Cholangiocarcinoma
09/2021 - 10/2013
4Thrombosis (Thrombus)
01/2021 - 06/2010
4Lymphopenia (Lymphocytopenia)
01/2021 - 01/2018
4Esophageal Neoplasms (Esophageal Cancer)
01/2019 - 07/2012
3Ataxia Telangiectasia (Louis Bar Syndrome)
01/2022 - 02/2015
3Melanoma (Melanoma, Malignant)
01/2022 - 07/2014
3Lung Neoplasms (Lung Cancer)
01/2020 - 01/2016
3Ascites
01/2019 - 09/2012
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 04/2012
3Fatigue
07/2012 - 11/2009
3Leukemia
05/2010 - 01/2009
2Body Weight (Weight, Body)
11/2022 - 05/2012
2Necrosis
01/2022 - 01/2011
2Head and Neck Neoplasms (Head and Neck Cancer)
12/2021 - 01/2019
2COVID-19
02/2021 - 11/2020
2Sarcoma (Soft Tissue Sarcoma)
01/2020 - 01/2005
2Glioma (Gliomas)
01/2020 - 01/2003

Drug/Important Bio-Agent (IBA)

24GoldIBA
11/2021 - 11/2007
19Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2008
11MicroRNAs (MicroRNA)IBA
01/2022 - 01/2016
11Protons (Proton)IBA
01/2021 - 01/2008
11Capecitabine (Xeloda)FDA Link
01/2016 - 10/2006
10Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2008
10Pharmaceutical PreparationsIBA
01/2022 - 04/2007
10GemcitabineFDA Link
12/2020 - 04/2007
9Biological ProductsIBA
01/2022 - 05/2010
9Fluorouracil (Carac)FDA LinkGeneric
12/2021 - 10/2006
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012 - 04/2007
7NF-kappa B (NF-kB)IBA
08/2010 - 04/2007
5Transcription Factors (Transcription Factor)IBA
11/2022 - 04/2008
5Cisplatin (Platino)FDA LinkGeneric
12/2021 - 02/2005
5ErbB Receptors (EGF Receptor)IBA
04/2012 - 01/2003
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2010 - 10/2007
4AntigensIBA
10/2022 - 05/2014
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2009
4Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016 - 07/2006
4Bevacizumab (Avastin)FDA Link
01/2016 - 12/2007
4Cyclin D1IBA
05/2012 - 04/2007
4Cetuximab (Erbitux)FDA Link
04/2012 - 12/2007
4CurcuminIBA
11/2009 - 04/2007
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2021 - 01/2017
3Therapeutic UsesIBA
11/2019 - 09/2012
3Contrast MediaIBA
01/2019 - 03/2009
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2016 - 05/2010
3Carcinoembryonic AntigenIBA
05/2016 - 05/2007
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2012 - 05/2010
3CaspasesIBA
11/2010 - 01/2009
2Phosphotransferases (Kinase)IBA
11/2022 - 10/2007
2Lapatinib (GW572016)FDA Link
01/2022 - 05/2015
2Yttrium-90IBA
01/2022 - 12/2007
2salicylhydroxamic acid (SHAM)IBA
12/2021 - 05/2018
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2021 - 05/2010
2GadoliniumIBA
01/2021 - 01/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2020 - 08/2010
2Photosensitizing Agents (Photosensitizers)IBA
10/2020 - 04/2017
2Lipid NanoparticlesIBA
10/2020 - 02/2020
2RNA (Ribonucleic Acid)IBA
07/2020 - 02/2018
2Arginine (L-Arginine)FDA Link
12/2019 - 01/2017
2Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2019 - 03/2012
2Liposomes (Liposome)IBA
08/2019 - 01/2017

Therapy/Procedure

91Radiotherapy
10/2022 - 01/2003
71Therapeutics
10/2022 - 01/2003
27Drug Therapy (Chemotherapy)
12/2021 - 01/2003
18Neoadjuvant Therapy
12/2021 - 11/2006
9Proton Therapy
07/2021 - 03/2009
8Re-Irradiation
10/2020 - 11/2009
6Heavy Ion Radiotherapy
01/2021 - 01/2015
6Chemoradiotherapy
06/2017 - 12/2006
5Immunotherapy
10/2020 - 09/2014
5Pancreaticoduodenectomy
01/2017 - 03/2008
4Microspheres (Microsphere)
01/2022 - 12/2007
4Aftercare (After-Treatment)
12/2021 - 10/2010
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2019 - 11/2009
4Induction Chemotherapy
12/2016 - 07/2007
3Precision Medicine
10/2020 - 01/2014
3Photothermal Therapy
05/2018 - 01/2012
3Oral Administration
08/2012 - 05/2010
2Segmental Mastectomy (Lumpectomy)
01/2022 - 03/2012
2Liver Transplantation
01/2022 - 06/2010
2Palliative Care (Palliative Therapy)
12/2021 - 12/2006
2Boron Neutron Capture Therapy
01/2021 - 08/2019
2Quantum Dots (Quantum Dot)
11/2019 - 07/2010